OSA's Digital Library

Biomedical Optics Express

Biomedical Optics Express

  • Editor: Joseph A. Izatt
  • Vol. 3, Iss. 4 — Apr. 1, 2012
  • pp: 764–776

Seeing it through: translational validation of new medical imaging modalities

Melissa B. Aldrich, Milton V. Marshall, Eva M. Sevick-Muraca, Greg Lanza, John Kotyk, Joseph Culver, Lihong V. Wang, Jashim Uddin, Brenda C. Crews, Lawrence J. Marnett, Joseph C. Liao, Chris Contag, James M. Crawford, Ken Wang, Bill Reisdorph, Henry Appelman, D. Kim Turgeon, Charles Meyer, and Tom Wang  »View Author Affiliations


Biomedical Optics Express, Vol. 3, Issue 4, pp. 764-776 (2012)
http://dx.doi.org/10.1364/BOE.3.000764


View Full Text Article

Enhanced HTML    Acrobat PDF (1764 KB)





Browse Journals / Lookup Meetings

Browse by Journal and Year


   


Lookup Conference Papers

Close Browse Journals / Lookup Meetings

Article Tools

Share
Citations

Abstract

Medical imaging is an invaluable tool for diagnosis, surgical guidance, and assessment of treatment efficacy. The Network for Translational Research (NTR) for Optical Imaging consists of four research groups working to “bridge the gap” between lab discovery and clinical use of fluorescence- and photoacoustic-based imaging devices used with imaging biomarkers. While the groups are using different modalities, all the groups face similar challenges when attempting to validate these systems for FDA approval and, ultimately, clinical use. Validation steps taken, as well as future needs, are described here. The group hopes to provide translational validation guidance for itself, as well as other researchers.

© 2012 OSA

OCIS Codes
(170.0110) Medical optics and biotechnology : Imaging systems
(170.3880) Medical optics and biotechnology : Medical and biological imaging

ToC Category:
Optics in Cancer Research

History
Original Manuscript: December 21, 2011
Revised Manuscript: February 10, 2012
Manuscript Accepted: February 13, 2012
Published: March 22, 2012

Citation
Melissa B. Aldrich, Milton V. Marshall, Eva M. Sevick-Muraca, Greg Lanza, John Kotyk, Joseph Culver, Lihong V. Wang, Jashim Uddin, Brenda C. Crews, Lawrence J. Marnett, Joseph C. Liao, Chris Contag, James M. Crawford, Ken Wang, Bill Reisdorph, Henry Appelman, D. Kim Turgeon, Charles Meyer, and Tom Wang, "Seeing it through: translational validation of new medical imaging modalities," Biomed. Opt. Express 3, 764-776 (2012)
http://www.opticsinfobase.org/boe/abstract.cfm?URI=boe-3-4-764


Sort:  Author  |  Year  |  Journal  |  Reset  

References

  1. L. V. Wang and S. Hu, “Photoacoustic tomography: in vivo imaging from organelles to organs,” Science (to be published).
  2. C. H. Kim, T. N. Erpelding, L. Jankovic, and L. V. Wang, “Performance benchmarks of an array-based hand-held photoacoustic probe adapted from a clinical ultrasound system for non-invasive sentinel lymph node imaging,” Philos. Transact. A Math. Phys. Eng. Sci.369(1955), 4644–4650 (2011). [CrossRef] [PubMed]
  3. C. H. Kim, T. N. Erpelding, K. Maslov, L. Jankovic, W. J. Akers, L. Song, S. Achilefu, J. A. Margenthaler, M. D. Pashley, and L. V. Wang, “Handheld array-based photoacoustic probe for guiding needle biopsy of sentinel lymph nodes,” J. Biomed. Opt.15(4), 046010 (2010). [CrossRef] [PubMed]
  4. C. H. Kim, T. N. Erpelding, L. Jankovic, M. D. Pashley, and L. V. Wang, “Deeply penetrating in vivo photoacoustic imaging using a clinical ultrasound array system,” Biomed. Opt. Express1(1), 278–284 (2010). [CrossRef] [PubMed]
  5. L. V. Wang, “Multiscale photoacoustic microscopy and computed tomography,” Nat. Photonics3(9), 503–509 (2009). [CrossRef] [PubMed]
  6. L. V. Wang, “Prospects of photoacoustic tomography,” Med. Phys.35(12), 5758–5767 (2008). [CrossRef] [PubMed]
  7. X. Wang, Y. Pang, G. Ku, X. Xie, G. Stoica, and L. V. Wang, “Noninvasive laser-induced photoacoustic tomography for structural and functional in vivo imaging of the brain,” Nat. Biotechnol.21(7), 803–806 (2003). [CrossRef] [PubMed]
  8. J. C. Rasmussen, I.-C. Tan, M. V. Marshall, C. E. Fife, and E. M. Sevick-Muraca, “Lymphatic imaging in humans with near-infrared fluorescence,” Curr. Opin. Biotechnol.20(1), 74–82 (2009). [CrossRef] [PubMed]
  9. J. C. Rasmussen, I.-C. Tan, M. V. Marshall, K. E. Adams, S. Kwon, C. E. Fife, E. A. Maus, L. A. Smith, K. R. Covington, and E. M. Sevick-Muraca, “Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence,” Transl Oncol3(6), 362–372 (2010). [PubMed]
  10. L. Sampath, S. Kwon, M. A. Hall, R. E. Price, and E. M. Sevick-Muraca, “Detection of cancer metastases with a dual-labeled near-infrared/positron emission tomography imaging agent,” Transl Oncol3(5), 307–317 (2010). [PubMed]
  11. M. V. Marshall, D. Draney, E. M. Sevick-Muraca, and D. M. Olive, “Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats,” Mol. Imaging Biol.12(6), 583–594 (2010). [CrossRef] [PubMed]
  12. M. A. Hall, S. Kwon, H. Robinson, P. A. Lachance, A. Azhdarinia, R. Ranganathan, R. E. Price, W. Chan, and E. M. Sevick-Muraca, “Imaging prostate cancer lymph node metastases with a multimodality contrast agent,” Prostate72(2), 129–146 (2012). [CrossRef] [PubMed]
  13. M. B. Aldrich, X. Wang, A. Hart, S. Kwon, L. Sampath, M. V. Marshall, and E. M. Sevick-Muraca, “Assessment of free dye in solutions of dual-labeled antibody conjugates for in vivo molecular imaging,” Mol. Imaging Biol.13(1), 32–42 (2011). [CrossRef] [PubMed]
  14. K. E. Adams, J. C. Rasmussen, C. Darne, I. C. Tan, M. B. Aldrich, M. V. Marshall, C. E. Fife, E. A. Maus, L. A. Smith, R. Guilloid, S. Hoy, and E. M. Sevick-Muraca, “Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema,” Biomed. Opt. Express1(1), 114–125 (2010). [CrossRef] [PubMed]
  15. A. J. Dannenberg, S. M. Lippman, J. R. Mann, K. Subbaramaiah, and R. N. DuBois, “Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention,” J. Clin. Oncol.23(2), 254–266 (2005). [CrossRef] [PubMed]
  16. M. M. Bertagnolli, C. J. Eagle, A. G. Zauber, M. Redston, S. D. Solomon, K. Kim, J. Tang, R. B. Rosenstein, J. Wittes, D. Corle, T. M. Hess, G. M. Woloj, F. Boisserie, W. F. Anderson, J. L. Viner, D. Bagheri, J. Burn, D. C. Chung, T. Dewar, T. R. Foley, N. Hoffman, F. Macrae, R. E. Pruitt, J. R. Saltzman, B. Salzberg, T. Sylwestrowicz, G. B. Gordon, E. T. Hawk, and APC Study Investigators, “Celecoxib for the prevention of sporadic colorectal adenomas,” N. Engl. J. Med.355(9), 873–874 (2006). [CrossRef]
  17. M. J. Edelman, D. Watson, X. Wang, C. Morrison, R. A. Kratzke, S. Jewell, L. Hodgson, A. M. Mauer, A. Gajra, G. A. Masters, M. Bedor, E. E. Vokes, and M. J. Green, “Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203,” J. Clin. Oncol.26(6), 848–855 (2008). [CrossRef] [PubMed]
  18. A. S. Kalgutkar, B. C. Crews, S. W. Rowlinson, A. B. Marnett, K. R. Kozak, R. P. Remmel, and L. J. Marnett, “Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors,” Proc. Natl. Acad. Sci. U.S.A.97(2), 925–930 (2000). [CrossRef] [PubMed]
  19. M. J. Uddin, B. C. Crews, A. L. Blobaum, P. J. Kingsley, D. L. Gorden, J. O. McIntyre, L. M. Matrisian, K. Subbaramaiah, A. J. Dannenberg, D. W. Piston, and L. J. Marnett, “Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents,” Cancer Res.70(9), 3618–3627 (2010). [CrossRef] [PubMed]
  20. P.-L. Hsiung, J. Hardy, S. Friedland, R. Soetikno, C. B. Du, A. P. Wu, P. Sahbaie, J. M. Crawford, A. W. Lowe, C. H. Contag, and T. D. Wang, “Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy,” Nat. Med.14(4), 454–458 (2008). [CrossRef] [PubMed]
  21. T. D. Wang, “Targeted imaging of flat and depressed colonic neoplasms,” in Non-Polypoid (Flat and Depressed) Colorectal Neoplasms. Gastrointestinal Endoscopy Clinics of North America, R. M. Soetikno and T. Kaltenbach, eds. (Elsevier Saunders, 2010).
  22. M. Goetz and T. D. Wang, “Molecular imaging in gastrointestinal endoscopy,” Gastroenterology138(3), 828–833.e1 (2010). [CrossRef] [PubMed]
  23. B. P. Joshi and T. D. Wang, “Exogenous molecular probes for targeted imaging in cancer: focus on multi-modal imaging,” Cancers2(2), 1251–1288 (2010). [CrossRef] [PubMed]
  24. S. J. Miller, B. P. Joshi, Y. Feng, A. Gaustad, E. R. Fearon, and T. D. Wang, “In vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probe,” PLoS ONE6(3), e17384 (2011). [CrossRef] [PubMed]
  25. S. F. Elahi, S. J. Miller, B. Joshi, and T. D. Wang, “Targeted imaging of colorectal dysplasia in living mice with fluorescence microendoscopy,” Biomed. Opt. Express2(4), 981–986 (2011). [CrossRef] [PubMed]
  26. S. J. Miller, C. M. Lee, B. P. Joshi, A. Gaustad, E. J. Seibel, and T. D. Wang, “Targeted detection of murine colonic dysplasia in vivo with flexible multi-spectral scanning fiber endoscopy,” J. Biomed. Opt. (to be published).
  27. P. L. Hsiung and T. D. Wang, “In vivo biomarkers for targeting colorectal neoplasms,” Cancer Biomark.4(6), 329–340 (2008). [PubMed]
  28. M. Li and T. D. Wang, “Targeted endoscopic imaging,” in Enhanced Endoscopic Imaging. Gastrointestinal Endoscopy Clinics of North America, K. Wang and G. Elta, eds. (Elsevier Saunders, 2009).
  29. T. D. Wang, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA, is preparing a manuscript to be called “Phase 1 study of molecular probes to colonic dysplasia.”
  30. S. S. Mehta, Commercializing Successful Biomedical Technologies (Cambridge University Press, 2008).
  31. S. L. Gibbs-Strauss, M. Rosenberg, B. L. Clough, S. L. Troyan, and J. V. Frangioni, “First-in-human clinical trials of imaging devices: an example from optical imaging,” in Annual International Conference of the IEEE Engineering in Medicine and Biology Society,2009. EMBC 2009 (IEEE, 2009), pp. 2001–2004.
  32. S. Gioux, H. S. Choi, and J. V. Frangioni, “Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation,” Mol. Imaging9(5), 237–255 (2010). [PubMed]
  33. Network for Translational Research, Handbook for NTR Investigators (Nov. 9, 2010), http://ntroi.wustl.edu/wiki/ntroi/images/d/d7/Handbook_for_NTR_Investigators_110910_for_upload.pdf .
  34. F. Wang, P. Hussels, and P. Liu, “Securely and flexibly sharing a biomedical data management system,” Proc. SPIE7264(726402), 1–8 (2009). [PubMed]
  35. B. Zhu, I. C. Tan, J. C. Rasmussen, and E. M. Sevick-Muraca, “Validating the sensitivity and performance of near-infrared fluorescence imaging and tomography devices using a novel solid phantom and measurement approach,” Technol. Cancer Res. Treat.11(1), 95–104 (2012). [PubMed]
  36. I. C. Tan, E. A. Maus, J. C. Rasmussen, M. V. Marshall, K. E. Adams, C. E. Fife, L. A. Smith, W. Chan, and E. M. Sevick-Muraca, “Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging,” Arch. Phys. Med. Rehabil.92(5), 756–764.e1 (2011). [CrossRef] [PubMed]
  37. W. A. Wells, P. E. Barker, C. MacAulay, M. Novelli, R. M. Levenson, and J. M. Crawford, “Validation of novel optical imaging technologies: the pathologists’ view,” J. Biomed. Opt.12(5), 051801 (2007). [CrossRef] [PubMed]

Cited By

Alert me when this paper is cited

OSA is able to provide readers links to articles that cite this paper by participating in CrossRef's Cited-By Linking service. CrossRef includes content from more than 3000 publishers and societies. In addition to listing OSA journal articles that cite this paper, citing articles from other participating publishers will also be listed.

Figures

Fig. 1 Fig. 2 Fig. 3
 
Fig. 4 Fig. 5
 

« Previous Article  |  Next Article »

OSA is a member of CrossRef.

CrossCheck Deposited